REXAHN PHARMACEUTICALS INC - COM (RNN)

CUSIP: 761640101

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM
Total 13F shares
11,959,561
Share change
+7,294,530
Total reported value
$12,917,776
Price per share
$1.08
Number of holders
35
Value change
+$7,942,595
Number of buys
30
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 761640101?
CUSIP 761640101 identifies RNN - REXAHN PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REXAHN PHARMACEUTICALS INC - COM (RNN) as of Q1 2014

As of 31 Mar 2014, REXAHN PHARMACEUTICALS INC - COM (RNN) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,959,561 shares. The largest 10 holders included VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, SPHERA FUNDS MANAGEMENT LTD., GEODE CAPITAL MANAGEMENT, LLC, AQR CAPITAL MANAGEMENT LLC, MORGAN STANLEY, UBS AG, PANAGORA ASSET MANAGEMENT INC, BlackRock Group LTD, and KCG HOLDINGS, INC.. This page lists 35 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.